{"schema_version":"1.0","type":"article","title":"RAS 標靶打開胰臟癌新局：生華科 CX-5461 卡位下一場「抗藥性管理」戰","url":"https://drugnews.com.tw/articles/2026-06-10-sinphar-cx5461-ras-pancreatic-cancer.html","markdown_url":"https://drugnews.com.tw/articles/2026-06-10-sinphar-cx5461-ras-pancreatic-cancer.md","lang":"zh-Hant","date":"2026-06-10","publish_at":"2026-06-10T10:45:00+08:00","updated_at":"2026-06-10","category":"商業分析系列","topic":"公司研究","tags":["生華科","CX-5461","Pidnarulex","RAS","胰臟癌","抗藥性","Tislelizumab"],"summary":"Daraxonrasib 打開胰臟癌 RAS 標靶時代後，真正的下一場戰爭是抗藥性管理；生華科 CX-5461 的價值在於能否成為 RAS 標靶後時代的免疫增敏與聯合治療候選策略。","key_points":[],"facts":[],"sections":["01｜RAS 被壓下去後，癌細胞會往哪裡逃？","02｜CX-5461：不是取代 RAS 抑制劑，而是補上抗藥性拼圖","03｜從冷腫瘤變熱，才是胰臟癌免疫治療的關鍵","04｜多路徑施壓，創造更高抗藥門檻","05｜FDA 同意收案設計，意義在於「進入真實抗藥性場景」","06｜不只胰臟癌，HRD 與 PARP 抗藥也是另一條價值線","07｜生華科真正要看的三個節點","結語｜RAS 抑制劑打開門，CX-5461 想守住下一道抗藥性關卡"],"references":[],"images":[{"alt":"RAS 標靶打開胰臟癌新局：Daraxonrasib 讓胰臟癌正式走向 RAS 標靶治療時代，下一場戰爭是抗藥性管理。","url":"https://drugnews.com.tw/assets/articles/sinphar-cx5461-ras-pancreatic-cancer/dcard-01.png"},{"alt":"RAS 被壓下去後，癌細胞可能轉向 MYC、KEAP1 / NRF2、YAP / TAZ / TEAD、腫瘤微環境重塑與免疫逃脫路徑。","url":"https://drugnews.com.tw/assets/articles/sinphar-cx5461-ras-pancreatic-cancer/dcard-02.png"},{"alt":"CX-5461 不是取代 RAS 抑制劑，而是透過核糖體壓力、DNA 損傷壓力與免疫活化，補上下一代聯合治療候選夥伴的拼圖。","url":"https://drugnews.com.tw/assets/articles/sinphar-cx5461-ras-pancreatic-cancer/dcard-03.png"},{"alt":"生華科 CX-5461 接下來要看的，是 RAS 抗藥性管理與 HRD / PARP 抗藥兩條價值線，以及試驗啟動收案、KRAS 陽性訊號與生物標記策略三個臨床追蹤節點。","url":"https://drugnews.com.tw/assets/articles/sinphar-cx5461-ras-pancreatic-cancer/dcard-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/sinphar-cx5461-ras-pancreatic-cancer/cover-cancer-cell.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-06-10）。RAS 標靶打開胰臟癌新局：生華科 CX-5461 卡位下一場「抗藥性管理」戰。https://drugnews.com.tw/articles/2026-06-10-sinphar-cx5461-ras-pancreatic-cancer.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-06-10-sinphar-cx5461-ras-pancreatic-cancer-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}